17 August 2017
Visiongain’s new report Global Anti-Inflammatory Therapeutics Market Report: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography indicates that the Anti-Inflammatory Therapeutics market will see over $75bn in revenue in 2017. The lead analyst of the report said:
“The Anti-Inflammatory Therapeutics market is expected to experience considerable growth over the forecast period. The main drivers for the growth include an increasingly ageing population, rising prevalence of arthritis and other immunological disorders and growing patient awareness of biologics and products available. In the US, more than 50 million adults and almost 300,000 children have arthritis or related conditions.
Between 2013-2015, around 54.4 million adults in the US (22.7% of all adults) had doctor-diagnosed arthritis, and 22.7 million (9.8%) had arthritis-attributable activity limitation. The prevalence of arthritis will increase in further years. The doctor diagnosed arthritis in US adults is forecast to 78.4 million (25.9% of all adults) in 2040 and the number of adults with arthritis-attributable activity limitation will increase to 34.6 million (11.4% of all adults). It was estimated that by 2040, one in four adults will have doctor-diagnosed arthritis. In UK, there are around 8 million adults have arthritis or related conditions.”
The 162-page report contains 108 tables, charts and graphs that add visual analysis in order to explain developing trends within the Anti-Inflammatory Therapeutics market. Visiongain provides revenue forecasts for the period 2017-2027 for the leading Anti-Inflammatory therapeutics submarkets, segmented by indication, including forecasts for Anti-Inflammatory Therapeutics for treating Arthritis, Respiratory conditions, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases and others. The Anti-Inflammatory Therapeutics market is also segmented by Drug Class, with forecasts for Corticosteroids, Anti-Inflammatory Biologics, NSAIDs and Other Anti-Inflammatory Therapeutics.
The 162-page report offers market forecasts and analysis for 11 key national markets. In addition, the report contains a dedicated leading companies’ chapter covering 10 companies leading the Anti-Inflammatory Therapeutics field in detail.
The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography report will be of value to anyone who wants to better understand the Anti-Inflammatory Therapeutics market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the anti-inflammatory therapeutics industry. Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.
24 January 2022
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.
18 January 2022
The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.
14 January 2022
With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.